Results 131 to 140 of about 1,978 (184)

Dapivirine Levonorgestrel Vaginal Ring: A multipurpose prevention ring for HIV and contraceptive protection [PDF]

Leveraging our experience developing the monthly dapivirine vaginal ring (DVR or “PrEP ring”), which received a positive opinion from the European Medicines Agency in 2020 for women’s HIV risk reduction, the Population Council is developing a 3-month ...
IPM South Africa
core   +1 more source

Use of Pharmacokinetic Data in Novel Analyses to Determine the Effect of Topical Microbicides as Preexposure Prophylaxis Against HIV Infection. [PDF]

, 2015
Vermund, SH, Walker, AS
core   +1 more source

Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa in the REACH Trial. [PDF]

J Acquir Immune Defic Syndr
Friedland BA, Browne EN, Roberts ST, Ngure K, Nakalega R, Macdonald P, Mpongo CN, Tenza S, Mhlanga N, Szydlo D, Johnson S, McClure T, Nair G, Celum C, Hillier SL, van der Straten A, MTN-034 REACH clinical trial team.   +16 more
europepmc   +1 more source

Corrigendum: Oral pre-exposure prophylaxis implementation in South Africa: a case study of USAID-supported programs

Frontiers in Reproductive Health
Jerome Wendoh Milimu, Lauren Parmley, Mahlodi Matjeng, Mathata Madibane, Mandisi Mabika, Jacques Livingston, Joseph Lawrence, Orapeleng Motlhaoleng, Hasina Subedar, Rethabile Tsekoa, Zandile Mthembu   +10 more
doaj   +3 more sources

The Current and Future Impact of WHO Guidance on Global HIV Pre-Exposure Prophylaxis Programs: A Narrative Review. [PDF]

Infect Drug Resist
Mishriky F, Chan PA.
europepmc   +1 more source

Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE. [PDF]

J Natl Cancer Inst
Hathaway CL, Brown ER, Cherne S, Sepulveda AL, Chirenje ZM, Jeenarain N, Naidoo L, Siva S, Singh N, Woeber K, Gaffoor Z, Mirembe BG, Kiweewa FM, Mansoor LE, Chinula L, Dadabhai S, Mugo NR, Palanee-Phillips T, Barnabas RV.   +18 more
europepmc   +1 more source

XVII International AIDS Conference: From Evidence to Action - Clinical and biomedical prevention science [PDF]

Mark Mascolini, Rodney Kort, David Gilden, Hammer, Emery, Baker, Hammer, Lima, Phillips, Ribaudo, Auvert, Bongaarts, Vernazza, Tsai, Peng   +14 more
core   +1 more source

A Review and Economic Analysis of the Dapivirine Vaginal Ring as HIV Pre-Exposure Prophylaxis for Women, to Inform South African Public-Sector Guidelines. [PDF]

J Acquir Immune Defic Syndr
Leong TD, Nel J, Jamieson L, Osih R, Dawood H, Subedar H, McCaul M, Johnson LF, Cohen K.   +8 more
europepmc   +1 more source

Counterfactual Groups to Assess Vaccine or Treatment Efficacy in HIV Prevention Trials in High-Risk Populations in Uganda. [PDF]

Vaccines (Basel)
Abaasa A, Mayanja Y, Anywaine Z, Kusemererwa S, Ruzagira E, Kaleebu P.   +5 more
europepmc   +1 more source

Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother-infant pairs (MTN-043): a phase 3B, open-label, randomised trial. [PDF]

Lancet HIV
Noguchi LM, Owor M, Mgodi NM, Gati Mirembe B, Dadabhai S, Horne E, Gundacker H, Richardson BA, Bunge K, Scheckter R, Song M, Marzinke MA, Anderson PL, Livant E, Jacobson C, Piper JM, Chakhtoura N, Hillier SL, Balkus JE, MTN-043 Study Team.   +19 more
europepmc   +1 more source